There is acompany with ASX code DOC (which has been mentioned here before) that has beengrowing quite rapidly in the telehealth space and which has been promoted bysome brokers/publications as a buy for the inevitable boom in telehealth. I also noticed some familiar names on the DOC forum that used to be RAP posters but I assume have since given up on RAP .
The question Ihave is how would DOC and all the other telehealth companies treat patients withrespiratory illnesses via telehealth if RAP is not used? Is there some alternativetelehealth treatment for respiratory problems? If there isn't an alternative currently then I am trying to fathom why RAP is not performing well.
